Prospective observational study reveals significant burden of chemotherapy-induced adverse drug reactions, suggesting improved treatment strategies are needed.
< 0.0001). Medication adherence declined with increasing age, with no patients aged ≥80 years demonstrating high adherence.ConclusionChemotherapy-induced ADRs represent a significant clinical and economic burden. Strengthened pharmacovigilance, individualized treatment strategies, and cost-effective interventions are essential to improve patient safety and optimize oncology care outcomes
No takes yet. Share an insight, caveat, or question.
Js et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: